ARTICLE | Company News
Schering-Plough exercises option on HGSI compound
October 9, 2000 7:00 AM UTC
SGP exercised its option to develop and market a type of interferon discovered by Human Genome Sciences. In 1996, HGSI granted SGP an option to develop and market two HGSI proteins as part of a therap...